# Jentadueto

NDC: 0597-0146
Generic name: linagliptin and metformin hydrochloride
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120213

FDA application: NDA201281

## Active ingredients

- LINAGLIPTIN: 2.5 mg/1
- METFORMIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0146"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0146
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597